Effectiveness of pantocrinum in the complex treatment of chronic kidney disease
Journal Title: Нирки - Year 2016, Vol 3, Issue 17
Abstract
The dynamics of chronic renal disease is presented for 25 patients, taking into account the effectiveness of Pantocrine. The study involved patients with chronic renal disease from I to V stages of different nosological reasons. The duration of the study was 8 weeks and treatment efficacy was weekly estimated. Effectiveness was assessed using the following criteria: general weakness, fatigue, exhaustion, sense of vitality and energy. According to obtained data, the effectiveness of Pantocrine in a complex treatment could be observed already from the first week of therapy. The assessment criteria used in this study show that after four weeks of treatment 20 % of patients did not experience general weakness, 40 % experienced slight general weakness, 28 % of patients did not experience fatigue and exhaustion, 40 % of patients felt burst of energy and revitalization most of the time. In addition, some of patients have noticed decrease of anxiety, despondency and depression; patients prone to hypotension observed normalization of blood pressure. Pantocrine is recommended to be included into treatment of patients with chronic renal disease.
Authors and Affiliations
N. O. Kolomiychuk
Keywords
Related Articles
- EP ID EP208324
- DOI 10.22141/2307-1257.3.17.2016.76456
- Views 91
- Downloads 0
Renin-Angiotensin System Blockers and Renal Functional Reserve. Is There a Limit of Renoprotection?
Renin-angiotensin system (RAS) blockers (angiotensin converting enzyme inhibitors, angiotensin receptor blockers, direct renin inhibitor) have a renoprotective effect in the presence of preserved glomerular filtration ra...
Symposium «Thrombotic Thrombocytopenic Microangiopathy»
.
Clinical Nephrology in Mutual Integration of Medical Professions
.
Changes in Renal Vascular Endothelium and Indicators of Endothelial Vascular Dysfunction in Systemic Autoimmune Rheumatic Diseases
Background. The renal endothelium is the primary barrier which reacts to systemic endothelial vascular dysfunction in patients with rheumatic diseases. The objective of the work was to evaluate the nature of morphologica...
Moxonidine in the treatment of chronic kidney disease associated with hypertension
Kidney disease pathogenesis is closely related to essential or secondary hypertension. Treatment of chronic kidney disease associated with hypertension requires a comprehensive causal and pathogenetic therapy. The topic...